drug

Antidepressant drug sales plummet as patents expire and patients flee to safer alternatives

Tuesday, April 03, 2012 by: Ethan A. Huff, staff writer
Tags: antidepressants, drug sales, alternatives

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
The five biggest lies about Ebola being pushed by government and mass media
Why does the CDC own a patent on Ebola 'invention?'
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Oregon man serving prison sentence for collecting rainwater on his own property
Russia taking McDonald's to court, threatens countrywide shutdown
Global warming data FAKED by government to fit climate change fictions
The best way to help your body protect itself against Ebola (or any virus or bacteria)
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
BREAKING: CDC whistleblower confesses to MMR vaccine research fraud in historic public statement
Monsanto's seed imperialism halted in Canada thanks to massive protests
Cannabis dissolves cancerous tumor in young infant, deemed a 'miracle baby' by physician
Top ten things you need to do NOW to protect yourself from an uncontrolled Ebola outbreak

Delicious
(NaturalNews) The market for antidepressant drugs is quickly drying up as patents on long-time blockbusters like Lexapro, owned by Forest Laboratories, and Seroquel, owned by AstraZeneca, continue to expire. And because they are unable to develop new multi-billion-dollar blockbuster drugs to take their places, many drug manufacturers are ditching the antidepressant business altogether, especially as studies continue to emerge showing that antidepressants are largely useless and cause more harm than good.

A recent Reuters report appears to bemoan the fact that development of a new antidepressant drug ceased after it was discovered that the drug was ineffective. Highlighting an overall trend of failure in this area of drug development within the drug industry, the report actually positions drug companies as victims that will stand to lose billions of dollars in profits as a result of their collective failure to come up with new drug options.

According to projections compiled by Thomson Reuters Pharma, worldwide sales of antidepressant drugs are expected to drop by more than half in the next four years. While antidepressant drugs raked in $15 billion in 2003, they are expected to fetch less then $6 billion by 2016 -- and there is no indication that this downward trend will slow any time soon.

Drug-makers also appear to be abandoning research and development of new antidepressants because an increasing number of patients are waking up to the ugly truth about their deadly side effects, and ditching them for safer alternatives. One such reminder of this disturbing truth came in the form of a 2010 study published in the Journal of the American Medical Association (JAMA), which found that antidepressants are basically useless for the vast majority of people who take them (http://www.naturalnews.com/028498_antidepressants_clinical_trials.html).

Antidepressants are also exceedingly dangerous, as they can lead to suicidal or homicidal tendencies in some patients. A study conducted by drug giant GlaxoSmithKline (GSK), for instance, revealed last year that its own antidepressant drug Paxil actually make patients worse off mentally, as they are more prone while taking the drug to attempt taking their own lives or the lives of others (http://www.naturalnews.com).

So rather than feel sorry for the drug industry which will have to "suffer" by taking in a few less billion dollars every year, the mainstream media and the public should be chiding Big Pharma for peddling these dangerous drugs in the first place, all the while having exploited the public all these years by charging obscene prices for them.

Sources for this article include:

http://www.reuters.com

http://www.utsandiego.com

http://www.healthcarefinancenews.com

http://www.investorplace.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.